<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Kerman University of Medical Sciences</PublisherName>
				<JournalTitle>International Journal of Health Policy and Management</JournalTitle>
				<Issn>2322-5939</Issn>
				<Volume>14</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Are Corporate Political Actors Aware of the Health Risks Associated With Their Products?; Comment on “Corporate Political Activity: Taxonomies and Model of Corporate Influence on Public Policy”</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>3</LastPage>
			<ELocationID EIdType="pii">4769</ELocationID>
			
<ELocationID EIdType="doi">10.34172/ijhpm.9104</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Emanuel</FirstName>
					<LastName>Orozco</LastName>
<Affiliation>Health Systems Research Centre, National Institute of Public Health, Morelos, Mexico</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>21</Day>
				</PubDate>
			</History>
		<Abstract>&lt;span class=&quot;fontstyle0&quot;&gt;The analytical model proposal by Ulucanlar et al for the analysis of corporate political activity (CPA) establishes that corporate actors are aware of the high incidence of non-communicable diseases (NCDs) associated with their products and protect themselves against the consequences. This model helps to identify the strategies used by various corporate entities to influence public policies and protect their interests. The CPA analytical model applies a critical approach to commercial determinants of health that allows us to understand how corporate actors take advantage of their systems-based management of power. Due to its inherent complexity, this analysis presents several unanswered questions requiring along with theoretical and empirical challenges. The situation described in this commentary points to the importance of monitoring the CPA at a global and local level, identifying opportunities that favor the regulation of political influence, to reduce the influence of the commercial determinants of health on the NCDs. &lt;/span&gt;</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Corporate Political Activity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Health Policy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Non-Communicable Diseases</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.ijhpm.com/article_4769_37622be8f7ed7432153a86708564d82a.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
